• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Cannabis Market
Cannabis News
Cannabis Stocks
  • Cannabis Market
  • Cannabis News
  • Cannabis Stocks
cannabis investing

Harvest Health & Recreation Issues Q4 and Year End 2018 Results

Bryan Mc Govern
Apr. 23, 2019 08:55AM PST
Cannabis Investing News

Harvest Health & Recreation announced its financial results for the Q4 and fiscal year 2018.

Harvest Health & Recreation (CSE:HARV,OTCQX:HRVSF) announced its financial results for the Q4 and fiscal year 2018.

As quoted in the press release:

“2018 continued to set records for Harvest’s growth and momentum across the United States,” said Chief Executive Officer Steve White. “Three key initiatives dictated our decisions throughout the year and will continue to be our focus in 2019: aggressively expanding our retail and wholesale footprint across the US, building, acquiring and expanding our suite of brands across our footprint and continuing to operate in a financially disciplined way, while also fueling the revenue growth of the company.”

Financial Highlights for the Fourth Quarter Ended December 31, 2018

  • Total revenue was US$16.9 million, an increase of 135 [percent], compared to US$7.2 million in Q4 2017.
  • Total revenue increased 52 [percent] compared to US$11.2 million in Q3 2018.
  • Gross profit, excluding impact of biological assets, was US$7.2 million, an increase of 342 [percent], up from US$1.6 million in Q4 2017.
  • Gross profit margin, excluding the impact of biological assets, was 42 [percent] and 23 [percent], respectively, for Q4 2018 and Q4 2017.
  • Adjusted EBITDA was US$2.6 million, compared to US$2.2 million in Q4 2017.
  • Net loss was US$71.1 million, for the three months ended December 31, 2018, and includes a non-recurring, non-cash fair value charge of US$50.7 million associated with convertible debt that was converted to equity during the year.

Click here to read the full press release.

cse:harv cannabis investing steve white
The Conversation (0)

Go Deeper

AI Powered

STEER Reports Record Revenues in Q1 2022

Biome Grow Quadruples Revenue, Triples Gross Profit in Q2, 2019

Latest News

More News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Cannabis Investing News Stocks

extractX

extractX (None)
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES